A third tal-1 promoter is specifically used in human T cell leukemias

Olivier Bernard, Orly Azogui, Nathalie Lecointe, Francine Mugneret, Roland Berger, Christian J. Larsen, Danièle Mathieu-Mahul

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    55 Citations (Scopus)

    Résumé

    A common feature of T cell acute lymphoblastic leukemias (T-ALLs) is the presence of structural alteration of the 5′ part of the tal-1 locus, localized on chromosomal band 1p32. These alterations consist of either a t(1;14)(p32;q11) chromosomal translocation (3% of T-ALLs) or tald submicroscopic deletion (12-25% additional T-ALLs). We have characterized a case of T-ALL with t(1;14)(p32;q11) in which, unlike the majority of t(1;14), the recombination with the T cell receptor δ elements affected the 3′ side of the tal-1 locus. In this case, tal-1 transcription is initiated from a promoter located within the fourth exon similarly to the DU 528 cell line. In a T-ALL bearing a t(1;14) affecting the 5′ part of tal-1, two types of tal-1 transcripts were observed, namely those probably initiated from the Do region juxtaposed to tal-1 by the translocation, and those from the exon 4 promoter. It is interesting that this exon 4 promotion was also found in leukemic T cell lines and T-ALL samples without apparent tal-1 genomic alteration. In contrast, no transcript initiated from the exon 4 promoter was found in T-ALL with tald2 or tald2 deletion. In these cells, tal-1 is expressed via SIL-tal-1 fused transcripts. Finally, this exon 4 initiation was detected neither in normal bone marrow, nor in malignant cells from the erythroid/megakaryocytic lineages. Taken as a whole, these data suggest that the exon 4 promoter is specifically active in T cell lineage.

    langue originaleAnglais
    Pages (de - à)919-925
    Nombre de pages7
    journalJournal of Experimental Medicine
    Volume176
    Numéro de publication4
    Les DOIs
    étatPublié - 1 oct. 1992

    Contient cette citation